Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 19168349

A randomised, double-blind, phase II study of two doses of pemetrexed in the treatment of platinum-resistant, epithelial ovarian or primary peritoneal cancer.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Eur J Cancer
Publication date
2009 May
First author
Vergote I

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Eur J Cancer. 2009 May;45(8):1330-2. doi: 10.1016/j.ejca.2009.02.006.
    note
    Source null
    related pmid
    19264477
    relationship
    Comment in

Authors and identifiers

  1. name
    Vergote I
    type
    Author
  2. name
    Calvert H
    type
    Author
  3. name
    Kania M
    type
    Author
  4. name
    Kaiser C
    type
    Author
  5. name
    Zimmermann AH
    type
    Author
  6. name
    Sehouli J
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Vergote I
    type
    Author
  2. name
    Calvert H
    type
    Author
  3. name
    Kania M
    type
    Author
  4. name
    Kaiser C
    type
    Author
  5. name
    Zimmermann AH
    type
    Author
  6. name
    Sehouli J
    type
    Author
bibliography ids
  1. nci-bib-3216ffbe69d518224e7b944e
book metadata
content sha256
2bdeeda0e549db732a18e16c91460ebc4ecb089eced47b29fd0cb2f2ca636403
document type
citation
dois
  1. 10.1016/j.ejca.2008.12.013
electronic publication date
display
2009 Jan 23
precision
day
year
2009
evidence scope
bibliographic_metadata_only
id
pubmed:19168349
immutable id
pubmed:19168349@2bdeeda0e549db732a18e16c91460ebc4ecb089eced47b29fd0cb2f2ca636403
journal
abbreviation
Eur J Cancer
issn electronic
1879-0852
issn print
0959-8049
issue
8
name
European journal of cancer (Oxford, England : 1990)
nlm unique id
9005373
pages
1415-23
volume
45
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Eur J Cancer. 2009 May;45(8):1330-2. doi: 10.1016/j.ejca.2009.02.006.
    note
    Source null
    related pmid
    19264477
    relationship
    Comment in
outcomes validated
false
pmid
19168349
provenance
batch id
27a383f06e5fc3d04fad
provider
NCBI PubMed ESummary
record sha256
3cfab24f64cab5bd0df2a7d95f48a27314092910fe7a1491f0bb65736edee3e1
response sha256
51f0f2a142dbd9b135e872b049b116f51941299445a5416feae10f12fac8d978
retrieved at
2026-09-09T23:46:24.265787+00:00
publication date
display
2009 May
precision
month
year
2009
publication types
  1. Clinical Trial, Phase II
  2. Comparative Study
  3. Journal Article
  4. Randomized Controlled Trial
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/19168349/
title
A randomised, double-blind, phase II study of two doses of pemetrexed in the treatment of platinum-resistant, epithelial ovarian or primary peritoneal cancer.

Preserved source evidence · Not medical advice